PT  - JOURNAL ARTICLE
ED  - , 
TI  - Correction: Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: A Phase I Study
AID  - 10.1158/1078-0432.CCR-15-21-COR1
DP  - 2009 Nov 01
TA  - Clinical Cancer Research
PG  - 6744--6744
VI  - 15
IP  - 21
4099  - http://clincancerres.aacrjournals.org/content/15/21/6744.short
4100  - http://clincancerres.aacrjournals.org/content/15/21/6744.full
SO  - Clin Cancer Res2009 Nov 01; 15